— Know what they know.
Not Investment Advice
Also trades as: 1911.HK (HKSE) · $vol 0M

CSCHF OTC

China Renaissance Holdings Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -9.1% 3Y: -53.3%
$0.60
+0.00 (+0.00%)
 
OTC · Financial Services · Investment - Banking & Investment Services · Tech Score Strong Sell · Power 40 · $343.0M mcap · 244M float · 0.0002% daily turnover · Short 81% of daily vol
#6 of 6
Investment - Banking & Investment Services
Financial Services · Small Cap · 9 peers
Market Share
2.0%
Top 4 Concentration: 84.8%

Technical Signal Map

1 Bullish
1 Neutral
8 Bearish

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
CSCHF China Renaissance Holdings Limited $340M 16.3 1.7 8.2 8.3 21.0 5 BEARISH -9.1
BRBI BRBI BR Partners S.A. ADSs $3.7B — — — — — — BULLISH -11.5
ITCFY Investec Group $7.9B 7.9 25.3 34.5 15.3 36.3 3 NEUTRAL 5.0
CURN Currency Exchange International, Corp. $130M 29.3 6.7 -184.4 23.5 -10.8 7 BEARISH 25.6
EFGZF EFG Holding S.A.E. Sponsored GDR RegS $720M 9.8 10.8 1.0 6.3 40.2 5 BEARISH 0.0
SFB Stifel Financial Corporation 5.20% Senior Notes due 2047 $1.9B 7.7 8.0 10.7 15.7 — 2 BEARISH —
PJT PJT Partners Inc. $3.5B 15.4 83.2 71.0 9.4 22.9 9 BEARISH -20.0
TCAPF TP ICAP Group plc $3.1B 12.4 18.1 -345.6 8.0 10.8 5 BEARISH 6.9
HLI Houlihan Lokey, Inc. $8.8B 20.8 18.8 28.8 15.7 9.5 9 BEARISH -36.8
PIPR Piper Sandler Companies $4.4B 14.4 23.6 29.4 13.7 34.7 5 BEARISH -80.7

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

CSCHF vs Benchmarks

ROIC
CSCHF
8.2
Industry
7.7
Gross Margin
CSCHF
100.0
Industry
76.8
Op Margin
CSCHF
10.3
Industry
21.0
Net Margin
CSCHF
8.3
Industry
12.9
Sector
19.5
Revenue Growth
CSCHF
21.0
Sector
6.7
P/E Ratio
CSCHF
16.3
Sector
12.8
ROE
CSCHF
1.7
Sector
9.1
Piotroski F
CSCHF
5.0
Sector
5.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms